Has the era of untreatable infections arrived?

Potency of SMP-601, a Novel Carbapenem, in Hematogenous Murine Bronchopneumonia Caused by Methicillin-Resistant and Vancomycin-Intermediate Staphylococcus aureus

(2008) R. Kihara et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter spp.

(2008) L. Poirel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States

(2008) D. C. Draghi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

First Report on a Hyperepidemic Clone of KPC-3-Producing Klebsiella pneumoniae in Israel Genetically Related to a Strain Causing Outbreaks in the United States

(2008) S. Navon-Venezia et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Spread of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in Istanbul, Turkey

(2008) A. Carrer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Novel Polymyxin Derivatives Carrying Only Three Positive Charges Are Effective Antibacterial Agents

(2008) M. Vaara et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Changing Epidemiology of Antimicrobial‐ResistantStreptococcus pneumoniaein the United States, 2004–2005

(2008) Sandra S. Richter et al.   CLINICAL INFECTIOUS DISEASES

Polymyxins Revisited

(2008) D. Landman et al.   CLINICAL MICROBIOLOGY REVIEWS

Acinetobacter baumannii: Emergence of a Successful Pathogen

(2008) A. Y. Peleg et al.   CLINICAL MICROBIOLOGY REVIEWS

Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives

(2008) Matthew E Falagas et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Current challenges in treating MRSA: what are the options?

(2008) Natasha VDV Ratnaraja et al.   Expert Review of Anti-Infective Therapy

Implementation of an Industrial Systems-Engineering Approach to Reduce the Incidence of Methicillin-Resistant Staphylococcus aureus Infection

(2008) Robert R. Muder et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06

(2008) D. M. Livermore et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Future directions with daptomycin

(2008) D. M. Livermore   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Linkage of acquired quinolone resistance (qnrS1) and metallo- -lactamase (blaVIM-1) genes in multiple species of Enterobacteriaceae from Bolzano, Italy

(2008) R. Aschbacher et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland

(2008) H. M. Palmer et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06

(2008) D. F. J. Brown et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests

(2008) A. Tsakris et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06

(2008) R. Hope et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum  -lactamases and carbapenemases

(2008) D. M. Livermore et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of conjugate pneumococcal vaccines on antibiotic resistance

(2008) Ron Dagan et al.   LANCET INFECTIOUS DISEASES

The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America

(2007) B. Spellberg et al.   CLINICAL INFECTIOUS DISEASES